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Available online 27 August 2016This study elucidated the stage-speciﬁc roles of FGF2 signaling during neural development using in-vitro human
embryonic stem cell-based developmental modeling. We found that the dysregulation of FGF2 signaling prior to
the onset of neural induction resulted in the malformation of neural rosettes (a neural tube-like structure), de-
spite cells having undergone neural induction. The aberrant neural rosette formation may be attributed to the
misplacement of ZO-1, which is a polarized tight junction protein and shown co-localized with FGF2/FGFR1 in
the apical region of neural rosettes, subsequently led to abnormal neurogenesis.Moreover, the FGF2 signaling in-
hibition at the stage of neural rosettes caused a reduction in cell proliferation, an increase in numbers of cells with
cell-cycle exit, and premature neurogenesis. These effects may be mediated by NUMB, to which expression was
observed enriched in the apical region of neural rosettes after FGF2 signaling inhibition coinciding with the
disappearance of PAX6+/Ki67+ neural stem cells and the emergence of MAP2+ neurons. Moreover, our results
suggested that the hESC-based developmental system reserved a similar neural stem cell niche in vivo.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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Neural stem cell niche1. Introduction
The fertilized egg develops into an embryo by initially undergoing
gastrulation at the stage of an implanted blastocyst, by which process
epiblasts in the blastocyst give rise to three primary germ layers (i.e. ec-
toderm, mesoderm, and endoderm). The central nervous system origi-
nates from the neural epithelium (NE) (the neural plate) derived from
the ectoderm. During neural development, the neural plate becomes
thicker, pseudo-stratiﬁed, and then forms the neural tube. The neural
tube develops into amulti-layered structure inwhich theNE constitutes
the innermost cell layer referred to as the ventricular zone (VZ) (Gilbert,
2010). In the VZ, NE cells and their offspring radial glial (RG) cells are
the founders for all neural cell types (i.e. neurons, astrocytes, and
oligodendrocytes).
The neural stem cell (NSC) niche that governs neural fates in the VZ
of the human cortex remains to be elucidated. TheNotch signaling path-
way (Gaiano and Fishell, 2002), neurotrophic factors, such as basic ﬁ-
broblast growth factor (FGF2) (Rash et al., 2013), epidermal growth
factor (Cameron et al., 1998), and the diffusible gas nitric oxide
(Cheng et al., 2003) have been shown to play important roles inNSC dif-
ferentiation in animal models. Although the key regulatory role of the
FGF2 pathway in the VZ niche was deﬁned in themaintenance and pro-
liferation of NSCs in mice (Jukkola et al., 2006; Kang et al., 2009; Rash etFaculty of Medicine, Masaryk
rno, Czech Republic.
. This is an open access article underal., 2011), the underlying mechanisms of its actions and its role during
early neural development (e.g. neural plate formation) are unknown.
The hindrance for progressing in this ﬁeld, especially in humans, is
mainly attributed to technical difﬁculties and ethical issues. The knowl-
edge of how our central nervous system develops is primarily derived
from animal models, which do not recapitulate fully the biological na-
ture of human brains, e.g. size, wiring, complexity, diversity of neural
cells, and structural organization. Thus the extrapolation from animals
to humans leads tomisperception, oversimpliﬁcation, and contradictory
conclusions. The lack of informative model systems that accurately rep-
resent human brain development restricts our capacity to evaluate the
biological processes during neural development.
The advent of pluripotent stem cell (PSC) technologies, including
embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC),
render invaluable tools for establishing human neural developmental
(Elkabetz et al., 2008; Sun et al., 2008; Curchoe et al., 2012; Shi et al.,
2012; Paşca et al., 2015) and disease modeling systems (Jung et al.,
2012; Feng and Gao, 2012; Peitz et al., 2013; Schadt et al., 2014;
Brennand et al., 2014; Imaizumi and Okano, 2014; Crook et al., 2015)
to underpin the molecular mechanisms underlying physiological and
pathological conditions in humans. The PSC-based modeling systems
are shifting the research landscape towards the investigation of
human conditions using human systems. To achieve this ambition, the
imperative task is to validate that the PSC system can recapitulate phys-
iological conditions in the human development, especially regulatory
niches. This study was undertaken to establish a human ESC-based
neurodevelopmental modeling system and further to elucidate thethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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focused on one of crucial elements in NSC niches, FGF2 signaling, and
deﬁned its stage-speciﬁc roles during neural development, by compar-
ing it with many facets of neural developmental events occurring in
mice, due to the unavailability of human embryos. Our results suggested
that human ESC-based neurodevelopmental modeling mimicked char-
acteristics of the neocortex and shared a similar functional proﬁle of
FGF2 signaling.
2. Materials and methods
2.1. Neural differentiation
Human ESCs (CCTL14 and CCTL12) (passage numbers 25–40) were
plated onto Matrigel-coated plates at 1000 cells/cm2, and changed to
N2B27 medium supplemented with 20 μM SB431542 (Tocris RD-
1614) next day, which was then replaced with fresh N2B27 medium
every other day as previously described (Lin et al., 2010; Matulka et
al., 2013). For cut-rosette experiments, neural rosettes appeared around
8-day differentiation, were harvested using manual cutouts and trans-
ferred to dishes pre-coated with ﬁbronectin (Sigma F1141) and
Matrigel. Neural rosettes were then cultured in N2B27 medium, which
was changed every 2 days until 30-day differentiation and thereafter
every 3 days. For uncut-rosette experiments, cells were cultured contin-
uously in N2B27 medium with the same way of medium changes de-
scribed above. Cells were collected and ﬁxed at various time points.
2.2. Time-lapse imaging
Rosette formation was ﬁlmed using the time-lapse system in
BioStation CT (Nikon Corporation, Japan). Image acquisition timing
was set to every 30 min from day 3 to day 8 of neural differentiation
and images were processed using built-in software. The interkinetic nu-
clear migration in neural rosettes was ﬁlmed 1 picture/10 min using a
confocal microscope system (LSM 700, Carl Zeiss GmbH, Germany).
The time-lapse movies and pictures were analyzed using Zen Blue and
Zen Black software (Carl Zeiss GmbH, Germany).
2.3. Immunocytochemical (ICC) analysis
ICC was performed as described previously (Matulka et al., 2013). In
general, ﬁxed cells were washed, permeabilized with 0.1% Triton X-100
in PBS for 1 h at room temperature and incubatedwith primary antibod-
ies [from Sigma: rabbit BLBP (1:600), mouse MAP2 (1:1000), rabbit
PARD3 (1:500), and rabbit vGLUT1 (1:500); from Santa Cruz: goat
GFAP (1:200), rabbit ZO-1 (1:300), goat DCX (1:400), rabbit FGF2
(1:100), mouse FGFR1 (1:300), rabbit FGFR2 (1:300), rabbit FGFR3
(1:300), rabbit FGFR4 (1:300), and rabbit Ki67 (1:500); mouse PAX6
(1:500, DSHB Iowa), and chicken Tbr2 (1:300, Millipore)] overnight at
4 °C. The next day cells werewashedwith PBS and sequentially incubat-
ed with DAPI (1:1500 in PBS) for 5 min and corresponding secondary
antibodies at room temperature for 1 h. The stained cells were exam-
ined using a confocal microscope (LSM 700, Carl Zeiss GmbH,
Germany).
2.4. Embryo preparation and immunohistochemical (IHC) analysis
Embryo preparation was approved by the Ministry of Education,
Youth and Sports (MSMT-19726/2015-4), Czech Republic and followed
the guidelines of the University Animal Care and Use Committee. The
embryos were collected at E8.0, E10.5, E12.5, E14.5, and E16.5, and im-
mediately transferred into 10% Formol. Embryos were ﬁxed and pre-
pared for 5 μm parafﬁn sections, which were de-parafﬁnized in
xylene-ethanol and had epitope antigen retrieval with 10 mM citrate
buffer (pH 6.0) for IHC. The brains of 60-day old male mice (P60)
were ﬁxed in 4% paraformaldehyde overnight at 4 °C and cryoprotectedwith 30% sucrose. For IHC, the brains were cut in 40 μm free-ﬂoating
sections using Leica cryostat and stored at −20 °C in cryoprotection
solution.
2.5. The treatment of FGF2 and inhibitors
For investigating the effect of FGF2 signaling on neural rosette for-
mation (equivalent to the stage of neural plate), cells were treated con-
tinuously with FGF2 and inhibitors from 2-day (+2D), 3-day (+3D), or
4-day (+4D) differentiation and cells were ﬁxed at 9 days of differenti-
ation. The drugs were FGF2 (10 ng/ml, PeproTech 100-18B), PD173074
(150 nM, Tocris 3044), PD184352 (5 μM, Santa Cruz sc-202759A),
LY294002 (10 μM, Santa Cruz sc-201426), and 10-DEBC·HCl (5 μM,
Tocris 2558). For investigating the effect of FGF2 signaling on neural ro-
settes (equivalent to the stage of the neural tube), the drugs were ad-
ministered to cut-rosettes, which were isolated from 11-day
differentiation, from day 12 and cells were ﬁxed at day 16.
2.6. The generation of ZO-1 knockdown (ZO1-KD)
The ZO1-KD hESC (CCTL 14) line was generated using a ZO-1 shRNA
vector (SHCLND-NM_175610, Sigma) and the mission PLKO.1-PURO
vector (SHC001, Sigma-Aldrich) as a control, following the methodolo-
gy described previously (Matulka et al., 2013). The knockdown clones
were veriﬁed by Western blotting analysis.
2.7. Inducible NUMB-eGFP system
A full-length NUMB cDNAwas ﬁrst inserted into the pEF1a-AcGFP1-
N1vector (Clontech) at EcoRI/BamHI sites to generate a NUMB-eGFP fu-
sion vector. A full-length NUMB-eGFP cDNA was then ampliﬁed with a
primer pair bearing BglII/MluI sites, which was digested with BglII/
MluI restriction enzymes and inserted into BglII/MluI sites of the
pTRE3G vector. The generated NUMB-eGFP/pTRE3G vector (Clontech)
was used to make a stably transfected hESC line, which was constitu-
tively expressing Tet-On 3G transactivator (pEF1α-TET3G). All the pro-
cedures followed the manufacturer's instructions.
2.8. RT-PCR
Total RNAs were isolated from the samples collected from different
days of neural differentiation (12, 16, 20, 24, 30, 40, 50, 60, 70, 80, and
90 days) using RNA Blue reagent (TopBio R013). The cDNAs from
those samples were synthesized with Transcriptor Reverse Transcrip-
tase (Roche) according to themanufacturer's protocol. RT-PCRwas per-
formed following the procedures described previously (Matulka et al.,
2013).
3. Results
3.1. Human ESC neural differentiation recapitulated the process from the
neural plate to the neural tube
Human ESCswere driven towards neural differentiation onMatrigel
in N2B27 media, which divided into various stages (Fig. 1A, top and
middle panels). We found that PAX6+ early NSCs occurred around
4 days of differentiation (called the onset of neural induction) (Fig. 1A,
bottom panel). When differentiation proceeded further, PAX6+ NSCs
aggregated to form neural tube-like rosettes (called the stage of neural
rosettes) (Fig. 1A). ZO-1 and PARD3, tight and adherens junctions' pro-
teins, gradually showed apical localization during neural rosette forma-
tion (Fig. 1B). They then developed a ring structure after the lumen
formation in neural rosettes, which resembles the structure of the neu-
ral tube (Fig. 1B). In general, the process of neural induction (equivalent
to neural plate formation) is deﬁned from human ESC differentiation
(day 1–2 onwards) to 4-day, in which cells were growing in a
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ered that the period of neural rosette formation (equivalent to neural
tube formation) is from 5 to 8 days of differentiation and the rosette
stage is at around day 8 onwards (Fig. 1A, top panel).
3.2. Neural rosette-based developmental modeling exhibited the character-
istics of embryonic cortex
3.2.1. The distribution of stage-speciﬁc neural cells
We further characterized our neural rosette system with various
stage-speciﬁc neural markers, PAX6 (early neural stem cells, NSCs),
BLBP (radial glia cells, RGC), TBR2 (intermediate neural progenitor
cells, INPC),MAP2 (panneurons), and vGLUT1 (glutamatergic neurons).
We found that PAX6+ NSCs appeared at around 4-day differentiation,
occupied the whole rosette, and gradually diminished as the rosette
structure elongated and formed a waterfall-like shape at around 24-
day differentiation (Fig. 2A,B). BLBP+ radial glia cells occurred later at
around 8 days of differentiation, also located in the entire rosette, and
were persistently present beyond 30 days of differentiation (Fig.
2A,B). Interestingly, the location of PAX6+ and BLBP+ cells in rosettes
bore a resemblance to that in the apical region of the embryonic cortex
which is the closest to the ventricular area (Fig. 2B), suggesting the ro-
sette region is equivalent to the most inner layer of the cortex. TBR2+
intermediate neural progenitors were produced at around 12 days of
differentiation and located at the peripheral area of rosettes, which is
equivalent to the second layer of the neocortex (Fig. 2A,B). We also
found that MAP2+ and vGLUT1+ neurons appeared from 12-day differ-
entiation onwards, mainly located in the peripheral region of rosettes
and were able to migrate out to other areas, which recapitulated the
properties of neurons distributed in the outer layer of the neocortex
(Fig. 2A,B). Furthermore, we investigated the neural fate decision span-
ning 90 days of differentiation using RT-PCR in this ESC-based system
(Fig. 2C).We adopted two systems, inwhich neural rosetteswere either
cut out or not cutout. In the cut-rosette system, NSCs were technically
enriched fromdifferentiation cultures and stage-speciﬁcmarkers exhib-
ited an enhanced expression corresponding to the developmental
stages, which shifted gradually from NSCs, RGCs, INPCs, to neurons
(Fig. 2C, left panel). In contrast, there were no discernible differences
in the expression of neural genes in the un-cut system (Fig. 2C, right
panel). It is worth noting our system primarily generated glutamatergic
neurons; that is consistent with the ﬁnding shown in Fig. 2A. Although
GABAergic neurons were few, if any (not shown), the expression of
GAD1 can be detected by PCR, whichmight suggestGAD1 is transcribed,
but not translated. This phenomenon may also apply to the genes for
midbrain, hindbrain, ventral, and neural crest (Fig. 2C). Interestingly,
our data showed that neurons appeared before astrocytes that only
came out after 60-day and 80-day differentiation in the un-cut and cut-
out systems, respectively (Fig. 2C), recapitulating the temporal appear-
ance of the neuronal and glial fate during neural development. Taken
together, for the neural rosette-based developmental modeling it is bet-
ter to use cut rosettes.
Our results suggested that temporal and spatial expression of neural
stage-speciﬁc markers in neural rosettes shares a similarity to those in
the embryonic cortex.
3.2.2. The interkinetic nuclear migration
NSCs residing in rosettes displayed interkinetic nuclear migration,
which recapitulated the characteristic behavior of NSCs in the embryon-
ic cortex. During the cell division, nuclei of NSCs migrated to the apical
region, divided, and moved back to their original location (Fig. 1).
3.2.3. Distribution of FGF2/FGFR1 in the rosette system recapitulated those
in the neocortex
The regulatory role of FGF2 signaling in neurogenesis in the embry-
onic cortex was well documented in mice. We adopted the FGF2
pathway as an example to elucidate that the neural rosette-baseddevelopmental modeling is a valid in-vitro system that recapitulates
the function of FGF2 signaling during neural development in vivo. We
initially compared the expression of FGF2 and FGFR1 in both systems.
FGF2 and FGFR1 were expressed in the embryonic brain region at
around E8.0, which is equivalent to day 6 in the neural rosette system
and both proteins showed cytosolic locations (Fig. 3A). When develop-
ment proceeded, FGF2 and FGFR1were present in the embryonic cortex
(E10.5) and in the entire neural rosette. At later stages (E12.5-E16.5),
both proteins gradually showed an apical location at the ventricular
area of the neocortex and in neural rosettes, which location was even
more pronounced after birth (P60) and in the late rosette (D30) (Fig.
3A). Our results suggest that the locations of FGF2 and FGFR1 in the neu-
ral rosette-based developmental system recapitulate those of the embry-
onic cortex. We also found that FGFR2, 3, and 4 were predominately
located at the apical region of neural rosettes that shared a similarity to
that of FGFR1 (Fig. 3B).
3.2.4. FGF2 impeded neural rosette formation and FGF2 signaling inhibition
altered early fate decision at the early stage of neural development
The FGF2 signaling possesses many pathways, including p-ERK,
PI3K, and AKT signaling pathways. We employed FGF2 and various se-
lective inhibitors to decipher the role of FGF2 signaling pathways in
early neural development from the neural induction to neural rosette
formation at different time points (+2D, +3D, and +4D) using our ro-
sette-based system (Fig. 4A, left panel). We examined the functions of
FGF2 signaling in cell survival, rosette formation, and the early fate de-
cision. We found that PD184352 (a MEK inhibitor, 5 uM) severely im-
paired cell survival (1%) from an early day treatment (+2D) (Table
S1), but the cell survival rate increased dramatically when the drug
treatment started at the later stage (+D4). LY294002 (a speciﬁc inhib-
itor of PI3K, 10uM) treatment also caused 45% cell death. PD173074 (an
inhibitor of FGFRs, 150 nM) had less impact on cell survival (85%),
whereas 10-DEBC hydrochloride (a selective inhibitor of protein kinase
AKT/PKB, 5 uM) showed little effect on cell death (8%). Furthermore,
FGF2 (10 ng/ml) did not increase cell proliferation as compared to the
control (Table S1). Our data suggested that FGF/p-ERK signaling had a
great impact on cell survival, especially at the early stage of hESC
differentiation.
Interestingly, neither FGF2 nor inhibitors of FGF2 signaling promot-
ed normal neural rosette formation (Fig. 4A). Except PD184352, we
found all inhibitor treatments resulted in themalformation of neural ro-
setteswithout an apical ZO-1 ring that indicated amature rosettewith a
lumen. Moreover, ZO-1 was diminished and scattered around rosettes,
suggesting neural rosettes were ill formed. Intriguingly, FGF2 treatment
did not show an opposite effect to that of inhibitors (e.g. the enlarge-
ment of neural rosettes). Instead, neural rosettes under the inﬂuence
of FGF2 exhibited a similar phenotype to those of inhibitor treatments
(Fig. 4A, right panel), which was corroborated with our observation in
the reduction of rosette numbers (Fig. 4B). Intriguingly, PD184352
treatment resulted in the generation of BLBP+/PAX6‐ cells with a big
and ﬂat phenotype, which may divert to astroglial cells (Fig. 4A). How-
ever, their end cells are needed to be determined. Our results indicated
that rosette formation required a balanced FGF2 signaling, which plays a
crucial role in the rosette niche that regulates neural fate decision.
3.2.5. ZO-1 played a part in the neural rosette disarray mediated by FGF2
signaling
As aforementioned, exogenous FGF2 and FGF2 signaling inhibitions
disrupted neural rosette formation and affected ZO-1 expression and
localization (Fig. 4A), we therefore sought to determine what the role
of ZO-1 was in the FGF2 signaling-mediated rosette disarray. First, we
found that FGF2, FGFR1, and ZO-1 were all located at the apical region
of neural rosettes by forming a ring structure, in which FGFR1 and ZO-
1 were co-localized in the outer layer of rings somewhat overlapped
with inner FGF2 rings (Fig. 5A), suggesting there were possible interac-
tions amongst these proteins. Thus the dysregulation of FGF2 signaling
Fig. 1.Human ESC-based neurodevelopmentalmodeling. (A) Various stages during neural differentiationwere designated (top panel), according to time-lapse images (middle panel) and
immunocytochemical analysis (bottom panel). The stages of neural development included the neural induction (the neural plate formation), the neural rosette formation (the neural tube
formation), and the neural rosette stage (the stage of neurogenesis). Human ESCs were plated out and driven towards neural differentiation. PAX6+ early NSCs appeared at around 4-day
differentiation (called neural induction) and they aggregated to form neural rosettes, towhich processwas called neural rosette formation characterizedwith a gradually apical location of
PARD3, an adherens junctions' protein. Neural rosettes are clearly seen at 8-day differentiation (circled and enlarged). (B) The process of neural rosette formation (middle and bottom
panels) recapitulates that of the neural tube formation from the neural plate in the schematic diagram (top panel). DAPI: blue; scale bar: 20 μm.
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rosette formation. To prove our hypothesis, we generated ZO-1
knockdown (ZO1-KD) hESC lines and the cells were driven towards
the stage of neural rosettes (Fig. 5B). We found that ZO1-KD cells
failed to form neural rosettes (Fig. 5B), and the phenotypes bore a
resemblance to those derived from the treatments of FGF2 and its
inhibitors (Fig. 4A). We also found that the apical rings formed by
FGFR1 and FGF2 were dismantled in ZO1-KD cells and FGFR1 exhib-
ited a cytosolic location while FGF2 showed a punctate feature (Fig.
5C). Our results suggested that ZO-1 might anchor FGFR1 at the
tight junction, whereas the FGF2 pathway regulates ZO-1 location
and expression, which is essential for the proper rosette formation.
We further examined the effect of ZO1-KD on neural differentiation
and found that neurogenesis was retarded in ZO1-KD hESCs, which
was also observed in hESC treated with either FGF2 or the inhibitors
of the FGF signaling pathway (Fig. 5D). Our ﬁnding showed that the
dysregulation of FGF2 signaling derailed the apical polarization of
ZO-1, which dismantled FGF2 signaling gradient by disrupting the
apical location of FGFR1 in neural rosettes that may lead to the im-
pairment in neurogenesis. Our results suggest FGF2 signaling consti-
tutes a crucial element of the niche resided within neural rosettes
that regulates the early neural fate.3.2.6. FGF2 diverted neural fate and inhibition of FGF2 signaling precipitat-
ed neurogenesis at the late stage of neural development
We further investigated the effect of FGF2 signaling on neural fates at
the rosette stage using a cut-rosette system, to which cells were treated
with drugs continuously from 12-day differentiation and ﬁxed at differ-
ent time points (Fig. 6A, top panel). We found that FGF2 and PD173074
treatments signiﬁcantly reduced the population ofproliferating PAX6+/
Ki67+NSCs at day 16 (Fig. 6A,B). FGF2 treatment signiﬁcantly increased
the number of proliferating PAX6‐/Ki67+ non-NSCs from D13 onwards,
while it signiﬁcantly diminished the number of PAX6+/Ki67‐ non-prolif-
erating cells at day 16 (Fig. 6A,B). Interestingly, the inhibition of FGF2 sig-
naling by PD173074 signiﬁcantly promoted cell cycle exit in PAX6+ cells
from day 15 and those cells then produced neuron-like processes at day
16 (Fig. 6A,B), which were conﬁrmed as early neurons that also stained
positively with DCX (Fig. 6C). Our results suggested that exogenous
FGF2 diverts neural fate without changing proliferation capacity while
inhibiting FGF2 signaling fast-tracks neurogenesis in the neural rosette
stage, which were also observed in the treatment of other FGF signaling
inhibitors (Fig. 2).Wewent further to examine long-term effects of FGF2
signaling on the neural fate decision. In the control, we found that
neurons gradually appeared from 16 days of differentiation, while
GFAP+ astrocytes only came out after 50-day differentiation (Fig. 6C).
Fig. 2. Neural rosettes possess the characteristics of the embryonic cortex. (A) Temporal and spatial expressions of stage-speciﬁc neural marker show similar patterns to those in the
embryonic cortex. Neural rosettes are structured into two regions, the apical region in the center of the rosette stained positively with ZO-1 and the basal region at the periphery of
rosettes. PAX6+ cells (early NSCs), BLBP+ cells (radial glia), TBR2+ cells (intermediate progenitors) and vGLUT1+ cells (glutamatergic neurons) appear from 4, 8, 12 and 12 days
ofdifferentiation, respectively. DAPI: blue; scale bar: 50 μm. (B) The comparison of the localization of neural stage-speciﬁc cells between the neural rosette (left panel) and the
embryonic cortex (middle panel), which is enlarged from the embryonic brain boxed region shown at the top right panel and images are adopted from Allen's Map (Collection of
Resources Available via the Allen Brain Atlas Data Portal). The summary of neural marker location (bottom right panel) in neural rosettes from the left panel, including PAX6+ and
BLBP+ cells in the whole rosette (green), TBR2+ cells in the outer layer of rosettes (yellow), whereas MAP2+ cells at the peripheral of rosettes (blue). Scale bar: 50 μm. (C) The
expression of neural-related genes in cut and un-cut rosettes during neural differentiation using RT-PCR. Samples were collected at different time points from 12-day to 90-day of
differentiation (indicated). Samples were analyzed for cell types, anteriorization, posteriorization, and dorsalization with speciﬁc markers. GAPDH and H2O (H) are the internal and
negative controls, respectively.
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from 30-day differentiation, because we observed many faint GFAP
staining that eventually became strong GFAP+ cells from day 50 (Fig.
6C). Conversely, the inhibition of FGF2 signaling prematurely triggered
neurogenesis so that astrogenesis was delayed due to possible depletion
of the NSC pool (Fig. 6C).
3.2.7. NUMB promoted neurogenesis mediated by the inhibition of FGF2
signaling
Our results showed that hESCs treated with the inhibitors of FGF2
signaling prematurely underwent neurogenesis (Fig. 6 and Fig. 2), sug-
gesting FGF2 signaling residing in the apical region of neural rosettes
maintained cells in a proliferating stem cell status while the inhibition
of the signaling prompted cells exiting the cell cycle to adopt the neuro-
nal fate. We examined if disrupting the neural rosette environment by
dissociating the cells could increase the number of cells undergone an
asymmetric division to exit the cell cycle. We found that a statisticallysigniﬁcant number of cells in a dissociated condition underwent an
asymmetric division (31.3% ± 4.7, n = 300) (Fig. 7A), as compared to
those in an intake rosette environment (2.7% ± 1.6, n = 300). In the
next step, we sought to ﬁnd out whether or not an asymmetric protein,
NUMB, took part in the neurogenesis accelerated after FGF2 signaling
inhibition by predisposing daughter cells to become neurons. We ob-
served that NUMBwas expressed strongly in the apical region of neural
rosettes that were treated with PD173074 (Fig. 7B). Surprisingly, those
cells that expressed NUMB strongly were often PAX6‐ cells, which ex-
hibited a reciprocally exclusive staining pattern (Fig. 7C), suggesting
that strong NUMB expression may have prompted PAX6+ NSCs to dif-
ferentiate towards neurons. To prove our hypothesis, we conducted an
experiment to test the effect of NUMB on PAX6+ NSCs using an induc-
ible NUMB-eGFP system, in which NUMB-eGFP proteins were generat-
ed under the control of Doxycycline treatments. We activated NUMB
production aroundneural induction by applyingDoxycycline intomedi-
um from 2-day differentiation and ﬁxed cells at 5-day differentiation
Fig. 3. The expression of FGF2 and FGFRs in the embryonic brain and neural rosettes. (A) The comparison of FGF2 and FGFR1 localization between the neural rosette and the embryonic
cortex. Mouse embryos (left panel) and human ESC-derived neural rosettes (right panel)were collected at different stages of development (indicated), and stainedwith FGF2 (green) and
FGFR1 (red). The boxed regions in the embryonic brain (left panel) are enlarged in themiddle and right panel. E: embryonic day; P: postnatal; D: differentiation day. Scale bars: 0.5mm in
embryos, 10 μm in cells, and 50 μm in neural rosettes. (B) The location of FGFR1, 2, 3, and 4 in neural rosettes. DAPI: blue; scale bars: 50 μm.
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cells were PAX6‐ and Ki67‐ cells (Fig. 7D, top panel), which supported
our ﬁndings shown in Fig. 7C, suggesting that NUMB promotes the cell
cycle exit to trigger neurogenesis. This notion is further corroboratedwith our ﬁnding that inducing NUMB expression in NSCs resulted in
the derivation of neurons judging by our observation that the cells
stained positively with MAP2 after Doxycycline treatment were
NUMB-eGFP+ (Fig. 7G, bottom panel). Our ﬁnding suggested that the
Fig. 4. The effects of FGF2 signaling on neural rosette formation and early neural fate decision. (A) Human ESCs were treated continuously with FGF2 and various inhibitors of FGF2
signaling (indicated) from 2-day (+2D), 3-day (+3D), and 4-day (+4D) of differentiation by a protocol summarized in a diagram (left panel). Cells were ﬁxed at 9-day differentiation
and were subjected to immunocytochemical analysis (right panel), which were stained with NSC marker PAX6 (green) and apical marker ZO-1 (red). DEBC (10-DEBC hydrochloride):
a selective inhibitor of AKT/PKB; LY294002: a speciﬁc inhibitor of PI3K/AKT kinase pathway; PD173074: an ATP competitive inhibitor of FGFRs; PD184352: an MEK Inhibitor. DAPI:
blue; scale bar: 20 μm. (B) Statistical analysis on the number of rosettes formed under the inﬂuence of FGF2 signaling. Data: Mean ± SD. **P b 0.01, signiﬁcantly different from the
control group. The experiment was repeated three times.
336 M. Grabiec et al. / Stem Cell Research 17 (2016) 330–341inhibition of FGF2 signaling-mediated precocious neurogenesis may be
partly due to the increased NUMB production.
4. Discussion
Others andwe have demonstrated that ESC-based developmental
modeling mimics a variety of neurodevelopmental events occurring
in vivo using either 2-D or 3-D systems. In those studies, the hESC-based developmental model has been proposed to imitate either
the neural plate (Elkabetz et al., 2008; Curchoe et al., 2012), the neu-
ral tube (Colleoni et al., 2010; Banda et al., 2015), or the cerebral cor-
tex (Shi et al., 2012; Lancaster et al., 2013; Paşca et al., 2015; Ziv et al.,
2015). In this study, we showed that the ESC-based system recapitu-
lated the progression from the neural plate, to the neural tube, and to
the cerebral cortex. We also found that the 2-D rosette-based devel-
opmental system exhibits a comparable capability in modeling
Fig. 5.ZO-1participated in the role of FGF2 signaling inneural rosette formation and early neural fate decision. (A) The locations of ZO-1, FGFR1, and FGF2were found to center in the apical
region of neural rosettes in ring structures. ZO-1 and FGFR1 were co-localized at the outer ring (middle panel), whereas both proteins showed an overlapping with FGF2 staining, which
was located in the inner ring (top andbottompanels). Z-stack views of ring structures show co-localization and overlapping in the far right panel (co-localization: yellow). Scale bar: 20 μm
and 10 μm(enlarged). (B) ZO-1 knockdownwas veriﬁedbyWestern blotting analysis (top panel). ZO-1 knockdown obviated the rosette formation. Cellswere stainedwith ZO-1 (red) and
PAX6 (green) (bottom panel). Scale bar: 50 μm. (C) The effect of ZO-1 knockdown on the locations of FGFR1 and FGF2. Scale bar: 10 μm. (D) Aberrant neurogenesis caused by ZO-1
knockdown and dysregulations of FGF2 signaling shared a similar phenotype. MAP2 (red) and BLBP (green). DAPI: blue; scale bar: 50 μm.
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(hCS) (Paşca et al., 2015).Both systems were able to capture the tem-
poral appearance of neural cells, for which the sequence from early
to late stages is NSCs, radial glial cells, intermediate progenitors,
neurons, and astrocytes. This was corroborated with studies in vivo
(Freeman, 2010).Additionally, the spatial locations of neural cells
showed a resemblance in both systems, including NSCs and radial
glial cells in the rosette, intermediate progenitors at the outer-layer
of rosettes, and neurons at the superﬁcial level in the 3-D system.
In the 3-D system, neurons were trapped within the sphere, while
neurons ran freely in the dish in our 2-D system.
We noticed that cut-out rosettes were better than uncut rosettes
while modeling neurodevelopment. First, stage-speciﬁc markers
exhibited a stage-relative enrichment in gene expression in the for-
mer, but not in the latter. Second, the former enriched the population
of neural cells so that neural gene expression was enhanced. Third,
gliogenesis occurred earlier in the latter, which suggested that the
environment in the latter may provide regulatory elements neededin glial cell production. Fourth, although we were able to detect
GAD1 expression, a marker for interneurons, we only found very
few GAD1+ cells, suggesting that GAD1 gene may be activated with-
out producing proteins. Interestingly, our paradigm generated pri-
marily glutamatergic neurons, which corroborated with our ﬁnding
that our modeling system recapitulated neurodevelopment in the
cerebral cortex.
In this study, we further established the neural niche residing in our
ESC-based developmental system also recapitulated that in in vivo. We
explored one of the crucial elements of neural niches, FGF2 signaling,
by deﬁning its stage-speciﬁc roles during neural development, which
showed characteristics reminiscent of its role in vivo, suggesting that
the NSC niche in neural rosettes may resemble that in the VZ of the em-
bryonic cortex. We found that the predominate apical localization of
FGF2 and FGFR1 in human neural rosettes that resembled those in the
VZ of the embryonic cortex in mice by gradually decreasing and
restricting to the end-feet or the ﬁrst layer of apical regions, which ech-
oed other observations made in vivo (Raballo et al., 2000; Frinchi et al.,
Fig. 6. The effects of FGF2 signaling on the neural fate decision, proliferation, and neurogenesis at the neural rosette stage. (A) A schematic diagram of the protocol used in this experiment
(top panel) depicts neural rosette colonies were cut out from 11-day differentiation of hESCs and placed onto new plates. The rosettes colonies were then treated with either FGF2 or
PD173074 continuously after settling overnight (D12). Cells were ﬁxed from day 13 to day 16 of differentiation and stained with PAX6 and Ki67. (B) Statistical analysis on the cells
presented in “A”. The characteristics of cells were analyzed and divided into proliferating NSCs (PAX6+/Ki67+), proliferating non- NSCs (PAX6‐/Ki67+), non-proliferating PAX6+cells,
and non-proliferating PAX6+ neuronal like cells. The experiments were repeated three times. Data: Mean ± SD. *P b 0.05 and **P b 0.01, signiﬁcantly different from the control group.
¥P b 0.05 and ¥¥P b 0.01, signiﬁcantly different from the FGF2-treated group. (C) Cells were treated with FGF2 or PD173074 continuously up to 50 days of differentiation and ﬁxed cells
at 16-day (D16), 30-day (D30), and 50-day (D50) differentiation and stained with stage-speciﬁc neural cells (indicated). DAPI: blue; scale bar: 50 μm.
338 M. Grabiec et al. / Stem Cell Research 17 (2016) 330–3412008; Guillemot and Zimmer, 2011). In the rosette system, the inhibi-
tion of FGF2 signaling with various inhibitors accelerated NSCs exiting
the cell cycle and leading to neurogenesis. Moreover, the inhibition de-
creased the size of neural rosettes, which corroborated in-vivo studiesthat the loss of FGF signaling by various FGFR knockouts leads to a
smaller cortex, a thinner proliferative area, decreased self-renewal of
VZ precursors, and premature neuronal differentiation (Jukkola et al.,
2006; Kang et al., 2009; Rash et al., 2011).
Fig. 7. NUMBmediated neurogenesis accelerated by FGF2 signaling inhibition. (A) An increased number of cells underwent an asymmetric division (indicated by arrows and enlarged in
the insert) after dissociating from neural rosettes. Neural rosettes were harvested from 11 days of differentiation, dissociated, and re-plated out onto new plates. Cells were ﬁxed and
stained with PAX6/Ki67 at 2 days, 3 days, and 4 days after plating out. An asymmetric division is shown in a pair of mitotic cells with one cell positively stained with PAX6/Ki67 and
the other negatively. Scale bar: 50 μm. (B) The inhibition of FGF2 signaling by PD173074 resulted in the enrichment of NUMB in the apical region of neural rosettes (top and middle
panels) (scale bars: 50 and 20 μm, respectively). The enlarged and Z-stack images of cells are shown in the bottom panel. The locations of apical and basal regions are indicated (scale
bar: 5 μm). (C) The enriched NUMB-eGFP production in cells was coincided with the withdrawal of PAX6 expression (red). The enlarged and Z-stack images of cells are shown in the
top panel (scale bar: 5 μm). (D) An inducible NUMB-eGFP expression system was established in hESCs. NUMB expression was induced by administering Doxycycline (Dox) at around
neural induction, which resulted in NUMB-eGFP expressed cells were PAX6‐ and Ki67‐ cells (+Dox) while hESCs predominately differentiated into PAX6+ NSC without the induction
of NUMB-eGFP expression (‐Dox) (top panel). When NUMB-eGFP expression was induced at the neural rosette stage, NUMB-eGFP+ cells were coincided with MAP2+ neurons
(bottom panel) (scale bars: 50 and 20 μm, respectively). DAPI: blue.
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hibition-mediated neurogenesis, in whichwe found that FGF2 signaling
inhibition enriched the apical location of NUMB. Moreover, the enrich-
ment of NUMB resulted in the disappearance of PAX6+ NSCs and the
emergence of MAP2+ neurons, suggesting NUMB is involved in
neurogenesis promoted by FGF signaling inhibition. It is known that
NUMB is a negative regulator of Notch, which controls numerous cellfate decisions during development by maintaining a proliferating and
undifferentiated fate (Cayouette and Raff, 2002; Chapman et al.,
2006). The NUMB action in promoting neurogenesis in our study may
occur via inhibiting the Notch pathway, because overexpressing
NUMB in cells promoted cell cycle exit (reducing Ki67+ cells) and reso-
nated the ﬁnding that the interplay between FGFs and Notch signaling
regulates neuronal differentiation (Faux et al., 2001). Strikingly, FGF2
340 M. Grabiec et al. / Stem Cell Research 17 (2016) 330–341treatments neither enlarged the size of neural rosettes nor sustained
PAX6+ NSCs, rather converting cells into PAX6‐ cells that remained
highly proliferating. They possibly shifted to the glial fate, because we
noticed that FGF2 treatments promoted astrogenesis that coincided
with the role of FGF2 in the induction of cortical progenitors to adopt
an astroglial fate at the expense of neuronal fates (Morrow et al.,
2001; Qian et al., 2000), and FGF2 knockout reduced the number of
GFAP+ cells in cortex and striatum(Reuss et al., 2003; Chen et al., 2008).
Studying the regulatory role of FGF signaling inmammalianneural
development primarily focuses upon the VZ of the neocortex (after neu-
ral tube formation, discussed above), whereas its earlier role in neural
induction is less explored. This may be due to the inaccessibility of
embryonic tissues at the stage of neural plate formation (~E7.5-
E8.7).Therefore, the function of FGF signaling in neural induction in
vivo are primarily derived from the studies of Xenopus (Sater et al.,
2003; Kuroda et al., 2005) and chickens (Streit et al., 2000; Wilson et
al., 2000; Stern, 2006; Stavridis et al., 2007), which found the FGF signal-
ing played a pivotal role in neural induction. Our in-vitro developmental
modeling system provided an invaluable tool to explore early neural
development in human. We found that FGF2 and its receptors are
expressed at around neural plate formation and a constant blockade of
the FGF2/p-ERK pathway with PD184352 treatment abolished neural
induction and adopted non-neural fate, which is in line with others'
and our previous ﬁndings in mouse and human ESCs (Kunath et al.,
2007; Stavridis et al., 2007; Cohen et al., 2010; Lin et al., 2010;
Matulka et al., 2013). Interestingly, a constant blockade or augmenta-
tion of FGF2 signaling (other than the FGF2/p-ERK pathway, e.g. PI3
and AKT/PKB pathways) during neural induction signiﬁcantly disrupted
neural rosette formation, but did not prevent cells from undergoing neu-
ral induction, which resulted in impeding or retarding in neurogenesis.
In contrast to the proliferating effect of FGF2 onNSCs, our results showed
that exogenous FGF2 impaired neural rosette formation. This might be
attributed to excess FGF2 derailing the polarization of ZO-1 during ro-
sette structuring, and this led to abolition of the apical-basal FGF2 signal-
ing gradient by disrupting FGFR1 apical localization. Our results suggest
that the FGF2 signaling gradient in neural rosettes is crucial in the NSC
niche to expand NSCs and to execute an orderly neural differentiation
by diversifying its regulatory roles with various FGF signaling pathways.
We further established the impairment in neurogenesismediated by
the dysregulation of FGF2 signalingmay be attributed to the disarrange-
ment of ZO-1, amarker of polarity, in the apical location,which resulted
in the deformation of neural rosettes that might lead to disarray of the
NSC niche within rosettes and causes abnormalities in neurogenesis.
This hypothesis was corroborated with our ﬁndings that knocking
down ZO-1 caused disorganized neural rosettes, dislodging apical loca-
tions of FGF2 and FGFR1, and a delay in neurogenesis, the phenotypes of
which were similar to those observed in FGF2 signaling inhibition, sug-
gesting reciprocal actions between NSC niches and polarized elements
in neural rosettes to maintain proliferating environment for orderly
neurogenesis. This notion was concomitant with our observation that
NSCs dissociated fromneural rosettes exhibited a propensity to undergo
an asymmetric division.Our results echoed the ﬁndings that proteins
involved in polarity play essential roles in neurogenesis (Compagnucci
et al., 2015; Banda et al., 2015; Singh and Solecki, 2015).
5. Conclusion
Collectively, our study demonstrated that hESC-based neural devel-
opmental modeling recapitulates the process from the neural plate to
the neural tube and, sequentially, the derived neural rosettes imitate
the ventricular region of the embryonic cortex with a similar structure
and NSC niche. One of the crucial elements of the NSC niche, FGF2 sig-
naling pathways, plays versatile roles in different stages of neural
development.
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